Alimera, pSivida eye implant finally wins U.S. approval

[riky]

Alimera, pSivida eye implant finally wins U.S. approval

By Vidya L Nathan and Anjali Rao Koppala (Reuters) - Alimera Sciences Inc and pSivida Corp said the U.S. Food and Drug Administration approved their vision-loss treatment Iluvien, following three rejections. Alimera's shares jumped about 16 percent to $5.95, while pSivida rose about 10.5 percent to $4.73 in extended trading. Iluvien will treat a condition known as diabetic macular edema (DME), a swelling on the back of the retina that in the most severe cases can lead to blindness. ...

Source: You are not allowed to view links. Register or Login